ArticleMolecular cancer2026

Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers.

Claudia Manriquez-Roman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.